Stockreport

Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development com [Read more]